Mark B. Hamner

Mark B. Hamner

Auto-generated profile, based on publicly available information

Mark B. Hamner

Behavioral Health Service, Ralph H. Johnson VA Medical Center, Charleston, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2018 in Cognitive Behaviour Therapy
Verified
Journal Article
Closed access
PTPeter W. Tuerk
Peter W. Tuerk
BWBethany C. Wangelin
Bethany C. Wangelin
MPMark B. Powers
Mark B. Powers
JSJasper A. J. Smits
Jasper A. J. Smits
RARonald ettore Acierno
Ronald ettore Acierno
MHMark B. Hamner
Mark B. Hamner
The alpha-2 adrenergic receptor antagonist, yohimbine, can facilitate fear extinction in animals and humans. One potential mechanism is increased noradrenergic activity and associated arousal in the presence of conditioned stimuli. Accordingly, yohimbine might augment prolonged exposure (PE) therapy for posttraumatic stress disorder (PTSD), where heightened exposure-oriented arousal is a theorized driver and empirical predictor of treatment success. A double-blind placebo-controlled randomized trial (NCT 01031979) piloted yohimbine augmentation in 26 males with combat-related PTSD. Participants were given one-time dose of yohimbine or placebo prior to the first imaginal exposure. Subsequently, both arms completed standard PE. The primary outcome was trauma-cued heart-rate reactivity a week after the drug/exposure visit, a highly specified, objective measure sensitive to incremental change. Secondary outcomes included arousal during the drug/exposure visit and slope of distress, PTSD, and depression over the course of PE. Consistent with hypothesis, yohimbine led to higher objective and subjective arousal during the drug/exposure visit and to lower trauma-cued heart-rate reactivity one-week later. One dose of yohimbine also led to greater between-session habituation and more rapid improvement on depression, but not PTSD, over the course of care. Results of this controlled pilot indicate support for continued investigation of yohimbine-augmented exposure therapy for PTSD.


12 September 2022 in Mindfulness
Verified
Journal Article
Closed access
PDF file
ISItamar Shapira
Itamar Shapira
JRJoshua Richman
Joshua Richman
TPThaddeus W. W. Pace
Thaddeus W. W. Pace
KLKelvin O. Lim
Kelvin O. Lim
MPMelissa A. Polusny
Melissa A. Polusny
LDLori L. Davis
Lori L. Davis

1 October 2017 in Journal of Anxiety Disorders
Verified
Journal Article
Open access
ZAZachary W. Adams
Zachary W. Adams
MMMichael Meinzer
Michael Meinzer
HMHoward Mandel
Howard Mandel
JVJoshua Voltin
Joshua Voltin
BCBlaine Caughron
Blaine Caughron
ZWZhewu Wang
Zhewu Wang
Attention-deficit/hyperactivity disorder (ADHD) and posttraumatic stress disorder (PTSD) are common among military veterans, but the comorbidity of these two psychiatric disorders remains largely unstudied. Evaluating response inhibition and cue-dependent learning as behavioral and neurocognitive mechanisms underlying ADHD/PTSD can inform etiological models and development of tailored interventions. A cued go/no-go task evaluated response inhibition in 160 adult males. Participants were recruited from the community and a Veterans Administration medical center. Four diagnostic groups were identified: ADHD-only, PTSD-only, ADHD+PTSD, controls. Group differences were observed across most indices of inhibitory functioning, reaction time, and reaction time variability, whereby PTSD-only and ADHD+PTSD participants demonstrated deficits relative to controls. No cue dependency effects were observed. Finding complement prior work on neurocognitive mechanisms underlying ADHD, PTSD, and ADHD+PTSD. Lack of expected group differences for the ADHD-only group may be due to limited power. Additional work is needed to better characterize distinctions among clinical groups, as well as to test effects among women and youth.

22 July 2015 in The Journal of Clinical Psychiatry
Verified
Journal Article
Closed access
PDF file
MHMark B. Hamner
Mark B. Hamner